Allan C. Collins

Q: What Schools Are Affiliated With Allan C. Collins

Allan C. Collins is affiliated with the following schools: University of Colorado Boulder, California Institute of Technology, University of Colorado

Allan C. Collins's AcademicInfluence.com Rankings

Allan C. Collins

Biology

#9295

World Rank

#12481

Historical Rank

Neuroscience

#1348

World Rank

#1394

Historical Rank

biology Degrees

Download Badge

Biology

Allan C. Collins's Degrees

PhD Neuroscience Stanford University

Why Is Allan C. Collins Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Allan C. Collins's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies (1997) (1391)
Guidelines on nicotine dose selection for in vivo research (2007) (747)
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization (2004) (686)
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. (1999) (599)
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. (1983) (497)
A method for fine mapping quantitative trait loci in outbred animal stocks. (2000) (453)
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. (2004) (435)
Effect of smoking history on [3H]nicotine binding in human postmortem brain. (1997) (411)
Characterization of Nicotinic Receptor‐Mediated [3H]Dopamine Release from Synaptosomes Prepared from Mouse Striatum (1992) (377)
Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia (2000) (338)
Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. (1982) (316)
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. (1985) (290)
Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. (1986) (288)
Chronic Nicotine Cell Specifically Upregulates Functional α4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path (2007) (270)
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. (2007) (260)
High-resolution mapping of quantitative trait loci in outbred mice (1999) (230)
Downregulation of nicotinic receptor function after chronic nicotine infusion. (1993) (210)
Genetic Correlation of Inhibitory Gating of Hippocampal Auditory Evoked Response and α-Bungarotoxin-Binding Nicotinic Cholinergic Receptors in Inbred Mouse Strains (1996) (208)
Why some people smoke and others do not: new perspectives. (1993) (191)
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors (2003) (190)
The CHRNA5/A3/B4 Gene Cluster Variability as an Important Determinant of Early Alcohol and Tobacco Initiation in Young Adults (2008) (178)
125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. (2000) (175)
Genetic influences on nicotine responses (1989) (173)
An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. (1991) (171)
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum (2001) (170)
UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes (2000) (166)
Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. (2002) (160)
Pharmacology of α-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice (2007) (152)
Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. (1998) (148)
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. (1998) (143)
Genetics of nicotine response in four inbred strains of mice. (1983) (141)
Involvement of the α3 Subunit in Central Nicotinic Binding Populations (2002) (136)
Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. (1996) (135)
Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. (1999) (133)
Desensitization of Nicotine‐Stimulated [3H]Dopamine Release from Mouse Striatal Synaptosomes (1994) (132)
An autoradiographic study of the distribution of binding sites for the novel α7‐selective nicotinic radioligand [3H]‐methyllycaconitine in the mouse brain (1999) (131)
Association of the neuronal nicotinic receptor β2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine (2007) (125)
Tolerance to and cross tolerance between ethanol and nicotine (1988) (125)
Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors (1989) (124)
Expression of Nigrostriatal α6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by β3 Subunit Gene Deletion (2005) (122)
The Role of RNA Editing of Kainate Receptors in Synaptic Plasticity and Seizures (2001) (121)
Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. (2002) (120)
Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. (1993) (118)
Neurosteroids Modulate Nicotinic Receptor Function in Mouse Striatal and Thalamic Synaptosomes (1997) (117)
Identification of a novel nicotinic binding site in mouse brain using [125I]‐epibatidine (2000) (115)
Genotype influences the development of tolerance to nicotine in the mouse. (1991) (113)
Dopamine-derived tetrahydroisoquinoline alkaloids--inhibitors of neuroamine metabolism. (1973) (104)
Variation of nicotinic binding sites among inbred strains (1989) (103)
Inbred mouse strains vary in oral self-selection of nicotine (1996) (102)
Prenatal nicotine alters nicotinic receptor development in the mouse brain (1994) (102)
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. (2003) (102)
The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. (2007) (99)
Postnatal Development of Cholinergic Enzymes and Receptors in Mouse Brain (1987) (99)
Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice. (2003) (97)
Nicotinic α5 subunit deletion locally reduces high‐affinity agonist activation without altering nicotinic receptor numbers (2007) (97)
Novel Seizure Phenotype and Sleep Disruptions in Knock-In Mice with Hypersensitive α4* Nicotinic Receptors (2005) (95)
Decreased ethanol sensitivity and tolerance development in gamma-protein kinase C null mutant mice is dependent on genetic background. (1999) (92)
Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. (1994) (91)
Age-Related Changes in Neuronal Nicotinic Acetylcholine Receptor Subunit α4 Expression Are Modified by Long-Term Nicotine Administration (1998) (91)
An autoradiographic analysis of cholinergic receptors in mouse brain (1989) (90)
Nicotine-induced tolerance and receptor changes in four mouse strains. (1986) (88)
Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors (1990) (87)
Genetic influence upon phenobarbital-induced increase in rat liver supernatant aldehyde dehydrogenase activity. (1972) (84)
An analysis of cocaine effects on locomotor activities and heart rate in four inbred mouse strains (1988) (83)
Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. (1986) (82)
Variations in alcohol metabolism: Influence of sex and age (1975) (80)
A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber (1993) (79)
Differential effects of central nervous system depressants in long-sleep and short-sleep mice. (1986) (77)
Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine (1985) (75)
Classical genetic analysis of nicotine-induced seizures and nicotinic receptors. (1984) (75)
Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. (1990) (74)
Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse (1988) (74)
Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation (2006) (74)
Conditional Expression in Corticothalamic Efferents Reveals a Developmental Role for Nicotinic Acetylcholine Receptors in Modulation of Passive Avoidance Behavior (2003) (74)
Increased Nicotinic Acetylcholine Receptor Protein Underlies Chronic Nicotine-Induced Up-Regulation of Nicotinic Agonist Binding Sites in Mouse Brain (2011) (74)
Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion. (2005) (73)
Involvement of the alpha3 subunit in central nicotinic binding populations. (2002) (72)
Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment (2004) (72)
Acetylcholine-Stimulated [3H]GABA Release from Mouse Brain Synaptosomes is Modulated by α4β2 and α4α5β2 Nicotinic Receptor Subtypes (2009) (70)
Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. (2007) (70)
Desensitization of Nicotine‐Stimulated 86Rb+ Efflux from Mouse Brain Synaptosomes (1994) (69)
Dose and route of administration alter the relative elimination of ethanol by long-sleep and short-sleep mice. (1986) (69)
Prostaglandin synthetase inhibitors antagonize the depressant effects of ethanol (1979) (68)
Influences of genotype and sex on behavioral tolerance to nicotine in mice (1977) (68)
Partial Deletion of the Nicotinic Cholinergic Receptor α4 or β2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of α4 and β2 Subunits (2008) (68)
A test battery for measuring nicotine effects in mice (1985) (67)
Increased Sensitivity to Agonist-Induced Seizures, Straub Tail, and Hippocampal Theta Rhythm in Knock-In Mice Carrying Hypersensitive α4 Nicotinic Receptors (2003) (67)
The subunit composition and pharmacology of α-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay (2005) (66)
Long-term ethanol and nicotine treatment elicit tolerance to ethanol. (1996) (66)
Regulation of Brain Nicotinic Receptors by Chronic Agonist Infusion (1991) (66)
Mecamylamine blockade of nicotine responses: Evidence for two brain nicotinic receptors (1986) (65)
Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol. (2005) (65)
Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes. (1996) (65)
A comparison of the development of tolerance to ethanol and cross-tolerance to nicotine after chronic ethanol treatment in long- and short-sleep mice. (1993) (61)
Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. (1997) (61)
Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. (2004) (61)
Influence of kinetics of nicotine administration on tolerance development and receptor levels (1987) (58)
Nicotine response and nicotinic receptors in long-sleep and short-sleep mice. (1987) (58)
Relationship between nicotine-induced seizures and hippocampal nicotinic receptors. (1985) (58)
Deletion of the α7, β2, or β4 Nicotinic Receptor Subunit Genes Identifies Highly Expressed Subtypes with Relatively Low Affinity for [3H]Epibatidine (2006) (58)
GABAergic Systems Modulate Nicotinic Receptor-Mediated Seizures in Mice (2003) (57)
Individual differences in oral nicotine intake in rats (2011) (55)
Mouse Striatal Dopamine Nerve Terminals Express α4α5β2 and Two Stoichiometric Forms of α4β2*-Nicotinic Acetylcholine Receptors (2009) (55)
Pharmacological and null mutation approaches reveal nicotinic receptor diversity. (2000) (55)
Mice Lacking PKCγ Exhibit Decreased Anxiety (2000) (54)
Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse. (1986) (54)
Genetic Approaches Identify Differential Roles for α4β2* Nicotinic Receptors in Acute Models of Antinociception in Mice (2007) (53)
Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition. (2001) (53)
Role of liver cytosolic aldehyde dehydrogenase isozymes in control of blood acetaldehyde concentrations. (1977) (53)
Evidence for modulation of GABAergic neurotransmission by nicotine (1988) (52)
The influence of genotype and sex on behavioral sensitivity to nicotine in mice (2004) (52)
Genetic influences on cholinergic drug response (1981) (52)
RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization. (1996) (50)
Cholinergic adaptations to chronic oxotremorine infusion. (1981) (50)
Interaction of the Nicotinic Cholinergic System with Ethanol Withdrawal (2004) (50)
α4β2 Nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response (2003) (49)
Potential regulation of nicotine and ethanol actions by alpha4-containing nicotinic receptors. (2001) (49)
Body temperature influences on ethanol elimination rate. (1987) (47)
Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice (2007) (47)
Immunolabeling demonstrates the interdependence of mouse brain α4 and β2 nicotinic acetylcholine receptor subunit expression (2006) (47)
Adrenocortical hormone regulation of nicotine sensitivity in mice (1988) (47)
α7-Nicotinic receptor expression and the anatomical organization of hippocampal interneurons (2001) (47)
Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. (1999) (46)
Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism. (2005) (46)
Genetic influences on tobacco use: a review of human and animal studies. (1990) (45)
Long-term ethanol treatment elicits changes in nicotinic receptor binding in only a few brain regions. (1997) (45)
A polymorphism in the alpha4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol. (2003) (45)
Chronic corticosterone administration enhances behavioral sensitization to amphetamine in mice (1993) (45)
A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function. (2002) (45)
Gene targeting demonstrates that α4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine (2007) (45)
A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice. (1993) (44)
An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation. (1993) (44)
Chronic corticosterone treatment alters sensory gating in C3H mice (2001) (43)
Are nicotinic receptors activated or inhibited following chronic nicotine treatment? (1996) (43)
Potential Role of the α4 and α6 Nicotinic Receptor Subunits in Regulating Nicotine-Induced Seizures (2000) (43)
Purification of L-[3H]nicotine eliminates low affinity binding. (1990) (42)
MECHANISMS THAT UNDERLIE SEX‐LINKED AND GENOTYPICALLY DETERMINED DIFFERENCES IN THE DEPRESSANT ACTIONS OF ALCOHOL * (1976) (40)
ST/b and DBA/2 mice differ in brain α-bungarotoxin binding and α7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis (1996) (40)
Sodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes. (1995) (40)
Circadian and genetic effects on ethanol elimination in LS and SS mice. (1982) (40)
Preferential inhibition of the low Km aldehyde dehydrogenase activity by pargyline. (1977) (39)
Genetically determined differences in acute responses to diisopropylfluorophosphate (1985) (39)
Postnatal development of two nicotinic cholinergic receptors in seven mouse brain regions (1990) (39)
Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone (2005) (39)
Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors (2000) (38)
Progress towards the development of animal models of smoking-related behaviors. (1991) (38)
Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. (2004) (38)
Nicotine tolerance: an analysis of the time course of its development and loss in the rat (2006) (38)
Classical genetic analyses of responses to nicotine and ethanol in crosses derived from long- and short-sleep mice. (1992) (37)
Linkage of strain-specific nicotinic receptor α7 subunit restriction fragment length polymorphisms with levels of α-bungarotoxin binding in brain (1996) (37)
Nonlinear pharmacokinetics of ethanol elimination in long sleep and short sleep mice. (1983) (36)
Synthesis and Characterization of 125I-α-Conotoxin ArIB[V11L;V16A], a Selective α7 Nicotinic Acetylcholine Receptor Antagonist (2008) (36)
Chronic nicotine exposure and brain nicotinic receptors--influence of genetic factors. (1989) (35)
Altered hippocampal circuit function in C3H α7 null mutant heterozygous mice (2008) (35)
Ethanol's behavioral effects may be partly due to increases in brain prostaglandin production. (1985) (35)
Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+ efflux and alpha4 nicotinic receptor subunit cDNA sequence. (2001) (35)
Responses to cholinergic agonists of rats selectively bred for differential sensitivity to ethanol. (1991) (35)
The pathophysiology of traumatic brain injury in α7 nicotinic cholinergic receptor knockout mice (2006) (35)
Quantitative trait locus analyses of sleep-times induced by sedative-hypnotics in LSXSS recombinant inbred strains of mice. (1996) (34)
Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the alpha 5 and alpha 7 nicotinic receptor subunit genes. (1998) (34)
Alpha 4 beta 2* nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response. (2003) (33)
Effects of pentobarbital in mice selected for differential sensitivity to ethanol (1982) (33)
Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in alpha4 and alpha6 nicotinic receptor genes. (2002) (33)
Genetic differences in plasma corticosterone levels in response to nicotine injection (1988) (33)
Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents (2004) (33)
Characterization of [125I]epibatidine binding and nicotinic agonist‐mediated 86Rb+ efflux in interpeduncular nucleus and inferior colliculus of β2 null mutant mice (2002) (31)
86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization. (2010) (31)
Antagonism of alcohol hypnosis by blockade of prostaglandin synthesis and activity: Genotype and time course effects (1983) (30)
The road to discovery of neuronal nicotinic cholinergic receptor subtypes. (2009) (30)
Hypersensitive knockin mouse strains identify receptors and pathways for nicotine action. (2003) (30)
A genetic analysis of nicotine effects on open field activity (1986) (30)
John Daly’s Compound, Epibatidine, Facilitates Identification of Nicotinic Receptor Subtypes (2009) (30)
A diallel analysis of nicotine-induced hypothermia (1984) (29)
Genotype regulates the development of tolerance to ethanol and cross-tolerance to nicotine. (1994) (29)
Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice. (2007) (29)
Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice (1996) (29)
Pharmacological and immunochemical characterization of α2* nicotinic acetylcholine receptors (nAChRs) in mouse brain (2009) (28)
Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion. (1990) (28)
Ethanol-nicotine interactions in long-sleep and short-sleep mice. (1990) (28)
Oral Nicotine Self-Administration in Rodents. (2012) (28)
Mice lacking PKC gamma exhibit decreased anxiety. (2000) (28)
Effects of Chronic Nicotine Infusion on Kinetics of High‐Affinity Nicotine Binding (1994) (27)
5α-pregnan-3α-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition (1990) (27)
Behavioral desensitization to nicotine is enhanced differentially by ethanol in long-sleep and short-sleep mice. (1989) (27)
Concentration-dependent effects of ethanol in long-sleep and short-sleep mice. (1983) (27)
Lipid solubility is correlated with hypnotic and hypothermic responses of long-sleep (LS) and short-sleep (SS) mice to various depressant drugs. (1983) (26)
Differential sensitivity of long-sleep and short-sleep mice to high doses of cocaine (1989) (26)
Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not other nicotinic antagonists (1990) (26)
Decreased sensitivity to nicotine-induced seizures as a consequence of nicotine pretreatment in long-sleep and short-sleep mice. (1988) (26)
Chronic scopolamine treatment and brain cholinergic function (1984) (26)
Use of genetic analysis to test the potential role of serotonin in alcohol preference. (1975) (25)
Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse (1990) (25)
Nicotinic-agonist stimulated 86Rb+ efflux and [3H]epibatidine binding of mice differing in β2 genotype (2000) (25)
Subcellular distribution of hepatic aldehyde dehydrogenase activity in four inbred mouse strains. (1981) (25)
I-a-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain (2000) (25)
Ethanol and acetaldehyde metabolism in the pregnant mouse. (1977) (24)
Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice (2005) (24)
Effect of nicotine pretreatment on nicotine-induced seizures (1988) (24)
Immunolabeling demonstrates the interdependence of mouse brain alpha4 and beta2 nicotinic acetylcholine receptor subunit expression. (2006) (24)
Norepinephrine, gamma-aminobutyric acid, and choline reuptake kinetics and the effects of ethanol in long-sleep and short-sleep mice. (1982) (23)
Ethanol-induced inhibition of GABA release from LS and SS mouse brain slices. (1984) (23)
Seizure susceptibility of the pregnant mouse (1982) (22)
Bovine serum albumin enhances nicotinic acetylcholine receptor function in mouse thalamic synaptosomes (2002) (22)
Acute ethanol effects on blood pH, PCO2, and PO2 in LS and SS mice (1982) (22)
Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice. (2002) (22)
Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. (2006) (21)
Ethanol and temperature effects on five membrane bound enzymes. (1984) (21)
A strain comparison of physiological and locomotor responses of mice to diisopropylfluorosphosphate (1986) (21)
Differential effect of chronic nicotine treatment on nicotinic receptor numbers in various brain regions of mice. (1989) (20)
7. – PHARMACOGENETICS OF ALCOHOLISM (1977) (20)
Interactions of ethanol and nicotine at the receptor level. (1990) (19)
Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP (1986) (19)
Effect of pyrazole in vivo on aldehyde metabolism in rat liver and brain. (1971) (19)
Potential role of the alpha4 and alpha6 nicotinic receptor subunits in regulating nicotine-induced seizures. (2000) (18)
Sensitivity to the Seizure-Inducing Effects of Nicotine is Associated with Strain-Specific Variants of the a 5 and a 7 Nicotinic Receptor Subunit Genes 1 (1998) (18)
Activating and anesthetic effects of general depressants (1978) (18)
Effects of three monoamine oxidase inhibitors on ethanol preference in mice (1977) (18)
Corticosterone reversibly alters brain α-bungarotoxin binding and nicotine sensitivity (1995) (17)
Animal models as a tool for studying mechanisms of co-abuse of alcohol and tobacco. (2002) (16)
An analysis of the addiction liability of nicotine. (1990) (16)
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. (2002) (16)
Ethanol-induced inhibition of norepinephrine release from brain slices obtained from LS and SS mice. (1984) (15)
Classical genetic analyses of responses to sedative-hypnotic drugs in crosses derived from long-sleep and short-sleep mice. (1992) (15)
A recombinant inbred strain analysis of sleep-time responses to several sedative-hypnotics. (1992) (15)
Quantitation of tolerance development after chronic oxotremorine treatment (1983) (15)
Time course of ethanol's effects on brain prostaglandins in LS and SS mice. (1986) (15)
Calcium Modulation of Activation and Desensitization of Nicotinic Receptors from Mouse Brain (1998) (14)
Differential effects of ethanol concentration on blood pH, PCO2 and PO2 in LS and SS Mice (1983) (14)
Background genotype modulates the effects of γ‐PKC on the development of rapid tolerance to ethanol‐induced hypothermia (2000) (14)
Nicotine interferes with GABA-mediated inhibitory processes in mouse hippocampus (1990) (14)
The effect of chronic nicotine treatment on nicotine-induced seizures (2004) (14)
Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes. (2014) (14)
A genetic analysis of ethanol, pentobarbital, and methyprylon sleep-time response. (1984) (14)
Sex differences in the recovery of brain acetylcholinesterase activity following a single exposure to DFP (1987) (13)
Increased CNS sensitivity to flurothyl as a measure of physical dependence in mice following morphine, phenobarbital, and ethanol treatment. (1976) (13)
A novel α‐conotoxin MII‐sensitive nicotinic acetylcholine receptor modulates [3H]‐GABA release in the superficial layers of the mouse superior colliculus (2012) (13)
Genetic influences on tolerance development with chronic oxotremorine infusion (1987) (13)
Selective mouse breeding for short ethanol sleep time has led to high levels of hepatic aromatic hydrocarbon (Ah) receptor. (1989) (12)
Quantification of physiological and behavioral measures of alcohol withdrawal in long-sleep and short-sleep mice. (1986) (12)
Differences in Response to Nicotine are Determined by Genetic Factors (1995) (12)
Behavioral effects of ethanol and salsolinol in mice selectively bred for acute sensitivity to ethanol (1984) (11)
Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors (1992) (11)
Bioavailability of ethanol is reduced in several commonly used liquid diets. (1994) (11)
Indomethacin significantly reduces mortality due to acute ethanol overexposure. (1982) (11)
Circadian and genetic influences on tissue sensitivity and sleep time to ethanol in LS and SS mice (1983) (11)
Differential effects of long-chain alcohols in long- and short-sleep mice (2004) (10)
Mast cell histamine and ovarian follicular growth in the lizard Anolis carolinensis. (1975) (10)
Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice. (1992) (10)
Linkage of strain-specific nicotinic receptor alpha 7 subunit restriction fragment length polymorphisms with levels of alpha-bungarotoxin binding in brain. (1996) (10)
Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog. (1997) (9)
Viability and sensorimotor development of mice exposed to prenatal short-term ethanol (1981) (9)
Brain NaK-ATPases in mice differentially sensitive to alcohols. (1984) (9)
Chronic corticosterone treatment elicits dose-dependent changes in mouse brain α-bungarotoxin binding (1996) (9)
Sulfhydryl Modification of Two Nicotinic Binding Sites in Mouse Brain (1988) (9)
Different levels of [3H]MK-801 binding in long-sleep and short-sleep lines of mice. (1996) (9)
ST/b and DBA/2 mice differ in brain alpha-bungarotoxin binding and alpha 7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis. (1996) (9)
Liver cytosolic aldehyde dehydrogenase activity in the pregnant mouse. (1981) (9)
Regulation of the Distribution and Function of [125I]Epibatidine Binding Sites by Chronic Nicotine in Mouse Embryonic Neuronal Cultures (2012) (8)
Indomethacin pretreatment blocks the effects of high concentrations of ethanol. (1985) (8)
The Effects of Chronic Nicotine Administration on Brain Nicotinic Receptor Numbers (1987) (8)
Animal models of alcoholism: genetic strategies and neurochemical mechanisms. (1993) (8)
The influence of age, sex and genotype on the subcellular distribution of hepatic aldehyde dehydrogenase activity in the mouse. (1982) (8)
Effects of ethanol and salsolinol on catecholamine function in LS and SS mice (1984) (8)
Cross-tolerance between muscarinic agonists: Role of muscarinic receptors (1987) (8)
Adrenalectomy reverses chronic injection-induced tolerance to nicotine (2005) (7)
Development of Nicotinic Agonists for the Treatment of Alzheimer’s Disease (1994) (7)
Genetic Studies of Nicotinic and Muscarinic Agents (1991) (7)
he CHRNA 5 / A 3 / B 4 Gene Cluster Variability as an mportant Determinant of Early Alcohol and Tobacco nitiation in Young Adults sabel (2008) (6)
A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice. (1990) (6)
Chronic intragastric infusion produces tolerance to ethanol in LS and SS mice. (1995) (6)
Prostaglandin synthetase inhibitors antagonize hypothermia induced by sedative hypnotics (2004) (5)
Components of the GABA system in mice selectively bred for differences in open-field activity (1980) (5)
Methaqualone: Tolerance and physical dependence in mice (1975) (4)
Corticosterone reversibly alters brain alpha-bungarotoxin binding and nicotine sensitivity. (1995) (4)
Reduction of alcohol selection by pargyline in mice (1976) (4)
Ethanol effects on 2-deoxyglucose uptake into tissues obtained from LS and SS mice. (1993) (4)
Mouse brain ATPase activities after chronic nicotine infusion. (1987) (4)
Brain arachidonic acid metabolites. Functions and interactions with ethanol. (1985) (3)
An analysis of response to nicotine infusion using an automated radiotelemetry system (1994) (3)
INDUCTION OF CYTOSOLIC ALDEHYDE DEHYDROGENASE ISOZYMES: INFLUENCE ON ACETALDEHYDE METABOLISM (1977) (3)
5 alpha-Pregnan-3 alpha-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition. (1990) (3)
Genetic regulation of nicotine-related behaviors and brain nicotinic receptors (2000) (3)
Sex and genotype influences of nicotine on motor activity, liver metabolism, neural sensitivity, and the acquisition of motor tolerance in inbred mice. Abstr. (1977) (3)
Regulation of Behavioral and Physiological Sensitivity to Nicotine by Brain Nicotinic Receptors (1988) (2)
Biochemical Measures of Nicotinic Receptor Desensitization (1995) (2)
Genetic Studies of Nicotine and Nicotine/Alcohol Reactivity in Humans and Animals (1992) (1)
Neuronal Nicotinic Receptors. Pharmacology and Therapeutics Opportunities Edited by Stephen P. Arneric and Jorge D. Brioni. Wiley-Liss, Inc., New York. 1999. xii + 421 pp. 16 x 24 cm. ISBN 0-471-24743-X. $175.00. (1999) (1)
An overview of the genetics of psychopathology (1982) (1)
C3H ALPHA7 NICOTINIC RECEPTOR HETEROZYGOTE MICE AS A NEW MODEL OF SCHIZOPHRENIA (2010) (1)
Indomethacin antagonism of ethanol-induced sleep time: Sex and genotypic factors (2004) (1)
The Nature of Addictive Diseases (1991) (1)
Synthesis and characterization of [ 125 I] α -conotoxin ArIB[V11L;V16A], a selective α 7 nAChR antagonist. (2008) (1)
Tissue Histamine Levels in the Lizard Anolis carolinensis (1976) (0)
Genetics of Ethanol Preference (1979) (0)
Mouse Models to Evaluate Genetic Influences on Responses to Nicotine (2001) (0)
ArIB(V11L;V16A), a Selective 7 Nicotinic Acetylcholine Receptor Antagonist □ S (2008) (0)
Organophosphates: Genetics Receptors and Antidotes. (1986) (0)
Potential role of corticosterone in regulating tolerance to nicotine (1990) (0)
159 Inheritance of a schizophrenia-like deficit in auditory gating fits a one gene model in inbred mouse strains (1997) (0)
Partial and full deletion of nicotinic acetylcholine receptor α4 and β2 subunits reduces sensitivity to acute nicotine administration and development of tolerance following chronic nicotine administration (2020) (0)
Ultra-fine mapping of quantitative trait loci (QTLs) (1998) (0)
Animal models of ethanol and nicotine interactions (2006) (0)
Expression of Nigrostriatal (cid:1) 6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by (cid:2) 3 Subunit Gene Deletion (2005) (0)
Neurochemical mechanisms in the genetics of alcohol phenotypes. (1985) (0)
Regulation of Various Responses to Nicotine by Different Nicotinic Receptor Subtypes (1991) (0)
Guest Editorial (2008) (0)
Fine mapping of QTLs for emotionally in mice as a model of human anxiety. (1997) (0)
Organophosphate Toxicity: Genetics, Receptors, and Antidotes (1983) (0)
Genetic influences on tolerance development and biochemical changes occuring with chronic nicotine treatment (1985) (0)
Nicotinic receptor regulation and tolerance (1994) (0)
Effect of chronic nicotine infusion on spatial learning ability (1990) (0)
Reduction of ethanol intake by pargyline. Abstr. (1976) (0)
Nicotine and smoking: Current controversies (1994) (0)
Behavioral Consequences of Neurotransmitter Receptor Regulation. (1987) (0)
Effects on transmitter release and ion fluxes (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Allan C. Collins?

Allan C. Collins is affiliated with the following schools: